Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Ischemia and CYP2C19[original query] |
|---|
| Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients. Genetics and molecular research : GMR 2015 14 (1): 1434-42. Sun B, Li J, Dong M, Yang L, Wu C, Zhu L, Cong Y |
| [THE FIRST RESULTS OF THE PREVALENCE OF CYP2C19 GENEPOLYMORPHISM IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE AKTYUBINSK POPULATION]. Georgian medical news 2016 Apr (253): 61-6. Smagulova G, Kulmurzaeva N, Seytmaganbetova N, Kurmanalina G, Talipova |
| Association of CYP2C19 and HSP70 Genes Polymorphism with Aspirin- Exacerbated Respiratory Disease in a Kurd Population. Endocrine, metabolic & immune disorders drug targets 2019 May . Kooti Wesam, Abdi Mohammad, Malik Yashpal S, Nouri Bijan, Jalili Ali, Rezaee Mohammad A, Rahmani Mohammad R, Kalmarzi Rasoul |
| Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial. JAMA 2020 08 324 (8): 761-771. Pereira Naveen L, Farkouh Michael E, So Derek, Lennon Ryan, Geller Nancy, Mathew Verghese, Bell Malcolm, Bae Jang-Ho, Jeong Myung Ho, Chavez Ivan, Gordon Paul, Abbott J Dawn, Cagin Charles, Baudhuin Linnea, Fu Yi-Ping, Goodman Shaun G, Hasan Ahmed, Iturriaga Erin, Lerman Amir, Sidhu Mandeep, Tanguay Jean-Francois, Wang Liewei, Weinshilboum Richard, Welsh Robert, Rosenberg Yves, Bailey Kent, Rihal Charanj |
| Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial. Stroke 2020 6 51 (7): 2058-2065. Meschia James F, Walton Ronald L, Farrugia Luca P, Ross Owen A, Elm Jordan J, Farrant Mary, Meurer William J, Lindblad Anne S, Barsan William, Ching Marilou, Gentile Nina, Ross Michael, Nahab Fadi, Easton J Donald, Kim Anthony S, Zurita Karla G, Cucchiara Brett, Johnston S Claibor |
| Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
| Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study. The pharmacogenomics journal 2021 3 21 (3): 402-408. Gronich Naomi, Lavi Idit, Lejbkowicz Flavio, Pinchev Mila, Zoabi Yusri, Auriel Eitan, Saliba Walid, Rennert G |
| CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD). American heart journal 2022 8 254 141-148. Kranendonk J, Willems L H, Vijver-Coppen Rj van der, Coenen M, Adang E, Donders R, Zeebregts C J, Deneer Vhm, Reijnen Mmpj, Kramers C, Warlé M |
| Sex-Specific Differences in Clinical Outcomes After Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. Journal of the American Heart Association 2022 6 11 (12): e024709. Madan Mina, Abbott J Dawn, Lennon Ryan, So Derek Y F, MacDougall Andrea M, McLaughlin Mary Ann, Murthy Vishakantha, Saw Jacqueline, Rihal Charanjit, Farkouh Michael E, Pereira Naveen L, Goodman Shaun G, |
| Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia. British journal of clinical pharmacology 2022 Feb . Minderhoud Crista, Otten Leila S, Hilkens Pieter H E, van den Broek Marcel P H, Harmsze Ankie |
| Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of integrative medicine 2022 Jan . Lin Yan-Jun, Jiao Kun-Li, Liu Bo, Fang Lu, Meng S |
| Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular drugs and therapy 2022 11 . Mathew Roy O, Sidhu Mandeep S, Rihal Charanjit S, Lennon Ryan, El-Hajjar Mohammed, Yager Neil, Lyubarova Radmila, Abdul-Nour Khaled, Weitz Steven, O'Cochlain D Fearghas, Murthy Vishakantha, Levisay Justin, Marzo Kevin, Graham John, Dzavik Vlad, So Derek, Goodman Shaun, Rosenberg Yves D, Pereira Naveen, Farkouh Michael |
| The contribution of genotype-guided selection of P2Y inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study. European journal of clinical pharmacology 2023 7 . Yan Wu, Dongbiao Yu, Lei Zhang, Yuting Wu, Bing Shu, Likun Ma, Tianlu S |
| The frequency of CYP2C19 loss-of-function variants in patients with non-cardioembolic ischemic stroke or transient ischemic attack in the Dutch population. Cerebrovascular diseases (Basel, Switzerland) 2023 3 . van den Heuvel Lotte, Vermeer Henricus J, Kerkhoff Henk, Roozenbeek Bob, Zock Ell |
| Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
- Page last reviewed:Feb 1, 2024
- Content source: